Key result
CABG in nonagenarians is linked to ~18% in-hospital mortality and universal morbidity despite symptomatic improvement.
Why the study?
Does coronary artery bypass grafting surgery improve outcomes in nonagenarians with refractory symptomatic coronary artery disease?
Observational (n=11)
Does coronary artery bypass grafting surgery improve outcomes in nonagenarians with refractory symptomatic coronary artery disease?
CABG in nonagenarians is feasible and can restore life expectancy and improve symptoms, but it is associated with high morbidity and prolonged hospital stays.
No takes yet. Share an insight, caveat, or question.
Should not yet change practice in nonagenarians; leaves open net benefit of CABG versus medical therapy in refractory CAD.
Miller et al. (1999) conducted an observational in Symptomatic coronary artery disease (n=11). Coronary artery bypass grafting surgery was evaluated on In-hospital death. Coronary artery bypass grafting in nonagenarians resulted in an 18% in-hospital mortality rate and 100% morbidity, with all survivors experiencing symptomatic improvement.